Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Endotoxin Testing of Intravenous Injections – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Endotoxin Testing of Intravenous Injections – V 2.0

Standard Operating Procedure for Endotoxin Testing of Intravenous Injections


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/062/2025
Supersedes SOP/SIM/062/2022
Page No. Page 1 of 14
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To describe the procedure for performing bacterial endotoxin testing (BET) on intravenous (IV) injectable drug products to ensure they comply with pharmacopeial limits using gel clot or chromogenic LAL test methods.

2. Scope

This SOP applies to all final IV injectable products

manufactured at [Company Name] that require endotoxin testing prior to batch release.

3. Responsibilities

  • Microbiology Analyst: Conducts the BET and documents the results.
  • QC Reviewer: Verifies results and checks calculations.
  • QA Personnel: Reviews test reports and ensures compliance with applicable specifications.

4. Accountability

The Head – Quality Control shall be accountable for ensuring implementation and compliance of the BET procedures.

See also  Sterile Injectable Manufacturing: SOP for Cleaning of Autoclaves Used in Sterile Manufacturing - V 2.0

5. Procedure

5.1 Preparation

  1. Ensure all glassware and equipment used are depyrogenated at 250°C for 30 minutes.
  2. Confirm that the LAL reagent, water for BET, and standard endotoxin are within expiry.
  3. Record lot numbers and preparation details in the Endotoxin Test Log (Annexure-1).

5.2 Sample Preparation

  1. Withdraw sample under aseptic conditions using pyrogen-free apparatus.
  2. Dilute sample appropriately based on Maximum Valid Dilution (MVD) and label test tubes.

5.3 Gel Clot Method

  1. Add 0.1 mL of sample or standard endotoxin to 0.1 mL LAL reagent in LAL test tubes.
  2. Include positive product control (PPC), negative product control (NPC), positive control (PC), and negative control (NC).
  3. Incubate tubes at 37±1°C for 60±2 minutes in a dry block incubator.
  4. After incubation, invert each tube gently. Presence of firm gel indicates a positive result.
See also  Sterile Injectable Manufacturing: SOP for Evaluating Freeze-Drying Parameters in Injectable Development - V 2.0

5.4 Chromogenic or Turbidimetric Method (Kinetic)

  1. Prepare microplate with required standards, samples, PPCs, and controls in duplicate.
  2. Add LAL reagent and read reaction kinetics in a validated microplate reader at specified wavelength.
  3. Use standard curve to calculate endotoxin concentration in sample.

5.5 Acceptance Criteria

  • Results must be below specified endotoxin limit (EU/mL) as per monograph or calculated using:
    Endotoxin Limit = K/M, where:

    • K = Threshold pyrogenic dose of endotoxin (generally 5 EU/kg for IV)
    • M = Maximum dose/kg/hour

5.6 Documentation

  1. Record observations in Annexure-1 and calculate results using Annexure-2.
  2. Report results in Annexure-3 and attach raw data printouts if applicable.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • LAL: Limulus Amebocyte Lysate
  • BET: Bacterial Endotoxin Test
  • EU: Endotoxin Unit
  • MVD: Maximum Valid Dilution

7. Documents

  1. Endotoxin Test Log – Annexure-1
  2. Endotoxin Limit Calculation Sheet – Annexure-2
  3. Endotoxin Test Report – Annexure-3
See also  Sterile Injectable Manufacturing: SOP for Cleaning of Lyophilizers Post-Batch Processing - V 2.0

8. References

  • USP <85> Bacterial Endotoxins Test
  • EP 2.6.14 Bacterial Endotoxins
  • ICH Q6A: Specifications

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation QC Analyst QC Manager Head QA
Department Quality Control Quality Control Quality Assurance

11. Annexures

Annexure-1: Endotoxin Test Log

Date Batch No. Product Method Analyst
17/06/2025 IVINF0021 Inj. Meropenem Gel Clot Pratik Jha

Annexure-2: Endotoxin Limit Calculation Sheet

Product Max Dose (mL/kg/hr) K Limit (EU/mL) MVD
Inj. Piperacillin 20 5 EU/kg 0.25 100

Annexure-3: Endotoxin Test Report

Product Batch Test Date Result (EU/mL) Status Reviewed By
Inj. Amikacin AMK-055 15/06/2025 0.18 Complies Shraddha Desai

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial version New SOP QA Head
18/06/2025 2.0 Included kinetic methods and calculation format Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: API Manufacturing: SOP for Preparation of Site Master File (SMF) – V 2.0
Next Post: Analytical Method Development: Aseptic Technique SOP for AMD – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version